Table 2.

Comparison of clinical outcomes after pulmonary surfactant therapy and morbidity in late selective and early prophylactic groups for pulmonary surfactant use in Korea

BPD, bronchopulmonary dysplasia; CPAP, continuous positive airway pressure; DIC, disseminated intravascular coagulation; EP, early prophylactic; IVH, intraventricular hemorrhage; LS, late selective; NEC, necrotizing enterocolitis; NICU, neonatal intensive care unit; PDA, patent ductus arteriosus; PIE, pulmonary interstitial emphysema; PPHN, persistent pulmonary hypertension; PTX, pneumothorax; ROP, retinopathy of prematurity.